Stocks and Investing Stocks and Investing
Tue, January 2, 2024
Fri, December 29, 2023
Thu, December 28, 2023
Wed, December 27, 2023
Tue, December 26, 2023
Fri, December 22, 2023
Thu, December 21, 2023
Wed, December 20, 2023

Charles Duncan Reiterated (AXSM) at Buy and Held Target at $108 on, Dec 20th, 2023


Published on 2024-10-28 08:05:48 - WOPRAI, Charles Duncan
  Print publication without navigation


Charles Duncan of Cantor Fitzgerald, Reiterated "Axsome Therapeutics, Inc." (AXSM) at Buy and Held Target at $108 on, Dec 20th, 2023.

Charles has made no other calls on AXSM in the last 4 months.



There are 3 other peers that have a rating on AXSM. Out of the 3 peers that are also analyzing AXSM, 0 agree with Charles's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Charles


  • David Hoang of "Citigroup" Initiated at Strong Buy and Held Target at $125 on, Wednesday, December 13th, 2023
  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $180 on, Tuesday, December 12th, 2023
  • Graig Suvannavejh of "Mizuho" Reiterated at Strong Buy and Held Target at $100 on, Monday, September 25th, 2023